Michel Dahan, SVP, Chief Operating Officer at Akebia Therapeutics, Inc. (AKBA), sold 10,744 shares at $1.52 ($16K) on 2024-02-27, disclosed to the SEC on 2024-02-29.
Open-market sale of $16k AKBA by SVP, Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AKBA | SELL | 2023-05-25 | $233K | — | Filing → |
| AKBA | SELL | 2023-03-03 | $18K | — | Filing → |
| AKBA | SELL | 2023-03-01 | $8K | — | Filing → |